Apollo Athenaa Cancer Conclave 2026: Advancing Precision in Breast Oncology

Reinforcing its commitment to advancing breast oncology, Apollo Hospitals will host the Apollo Athenaa Cancer Conclave 2026 on 7–8 March 2026, at The Suryaa in New Delhi. The event will convene leading oncologists, surgeons, radiologists, pathologists, and researchers to advance multidisciplinary breast cancer care. Organised by the Apollo Athenaa Women's Cancer Centre in Delhi — Asia’s first dedicated cancer centre for women — the conclave is themed “From Grey Zones to Black & White in the Management of Breast Cancer.”

The scientific programme will highlight precision oncology, comprehensive genomic profiling, and tumour cartography, emphasising the convergence of imaging, pathology, and molecular diagnostics in personalised treatment planning. Key sessions will address axillary management after neoadjuvant systemic therapy (NAST), immunotherapy in triple-negative breast cancer (TNBC), CDK4/6 inhibitors in high-risk HR+, HER2- early breast cancer, and advances in oncoplastic and reconstructive surgery. Dedicated workshops on digital pathology, vacuum-assisted breast biopsy (VABB), and grossing techniques will further strengthen diagnostic accuracy and surgical precision.

International faculty from Germany, Spain, the UAE, and the UK will join Indian experts to share global emerging evidence and clinical insights. The conclave underscores Apollo Athenaa’s focus on precision, progress, and personalisation in breast cancer care.

To know more: https://apolloathenaacancerconclave.com/